Kukje Pharma Co (XKRX:002720) Days Sales Outstanding : 48.79 (As of Mar. 2025)

View and export this data going back to 1975. Start your Free Trial

What is Kukje Pharma Co Days Sales Outstanding?

Kukje Pharma Co's average Accounts Receivable for the three months ended in Mar. 2025 was ₩22,190 Mil. Kukje Pharma Co's Revenue for the three months ended in Mar. 2025 was ₩41,504 Mil. Hence, Kukje Pharma Co's Days Sales Outstanding for the three months ended in Mar. 2025 was 48.79.

The historical rank and industry rank for Kukje Pharma Co's Days Sales Outstanding or its related term are showing as below:

XKRX:002720' s Days Sales Outstanding Range Over the Past 10 Years
Min: 47.37 Med: 68.14 Max: 125.4
Current: 47.37

During the past 13 years, Kukje Pharma Co's highest Days Sales Outstanding was 125.40. The lowest was 47.37. And the median was 68.14.

XKRX:002720's Days Sales Outstanding is ranked better than
76.49% of 957 companies
in the Drug Manufacturers industry
Industry Median: 72.09 vs XKRX:002720: 47.37

Kukje Pharma Co's Days Sales Outstanding declined from Mar. 2024 (49.44) to Mar. 2025 (48.79).

Kukje Pharma Co Days Sales Outstanding Historical Data

The historical data trend for Kukje Pharma Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kukje Pharma Co Days Sales Outstanding Chart

Kukje Pharma Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Sales Outstanding

Get a 7-Day Free Trial

57.27

62.34

57.36

53.33

50.38

Kukje Pharma Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Days Sales Outstanding	Get a 7-Day Free Trial															49.44	49.18	45.44	45.93	48.79

Competitive Comparison of Kukje Pharma Co's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Kukje Pharma Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kukje Pharma Co's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kukje Pharma Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Kukje Pharma Co's Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

Kukje Pharma Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Kukje Pharma Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

	Days Sales Outstanding (A: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (20429.245	+	22761.083)	/	2 )	/	156462.823	*	365
=	21595.164					/	156462.823	*	365
=	50.38

Kukje Pharma Co's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding (Q: Mar. 2025 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2024 )	+	Accounts Receivable (A: Mar. 2025 ))	/	count )	/	Revenue (A: Mar. 2025 )	*	Days in Period
=	( (22761.083	+	21618.188)	/	2 )	/	41504.339	*	365 / 4
=	22189.6355					/	41504.339	*	365 / 4
=	48.79

Kukje Pharma Co (XKRX:002720) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Kukje Pharma Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Kukje Pharma Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Kukje Pharma Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kukje Pharma Co Ltd (XKRX:002720) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

N/A

Address

96-8 Yatapiro, Bundang-Gu, Seongnam-si, Gyeonggi, KOR, 463-839

Website

http://www.kukjepharm.co.kr

Kukje Pharma Co Ltd engages in manufacturing, importing, exporting, selling, and distributing pharmaceutical products internationally. The company offers pharmaceutical products, including ETC and OTC products, raw materials, intermediates, and side chain products, as well as cosmetics and health care products. Its products include cephalosporins, penicillins, quinolones, aminoglycosides, macrolides, antifungal and antiviral agents, and other antibiotics.

Kukje Pharma Co Headlines

No Headlines